Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …

Leishmaniasis is caused by protozoan Leishmania parasites that are transmitted through
female sandfly bites. The disease is predominantly endemic to the tropics and semi-tropics …

Leishmania parasites have been widely used in experimental models to understand
generation, maintenance and failure of immune responses underlying resistance and …

BACKGROUND: Cutaneous leishmaniasis (CL) has traditionally been underrecognized and
underreported. Improved awareness is warranted as the number of cases has increased as …

Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement
and fatal systemic infection. WHO estimates that the disease results in 2 million new cases a …

No vaccine is currently available for visceral leishmaniasis (VL) caused by Leishmania
donovani. This study addresses whether a live attenuated centrin gene-deleted L. donovani …

Live attenuated Leishmania donovani parasites such as LdCen−/− have been shown elicit
protective immunity against leishmanial infection in mice and hamster models. Previously …

Leishmaniasis is a neglected disease resulting in a global morbidity of 2,090 thousand
Disability‐Adjusted Life Years and a mortality rate of approximately 60,000 per year. Among …

Visceral leishmaniasis (VL) is a disease transmitted by phlebotomine sand flies, fatal if
untreated, and with no available human vaccine. In rodents, cellular immunity to Leishmania …

Leishmaniasis is a protozoan parasitic disease endemic to the tropical and subtropical
regions of the world, with three major clinical forms, self‐healing cutaneous leishmaniasis …